These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 30608548)

  • 1. Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma.
    Kobayashi H; Abe Y; Miura D; Narita K; Kitadate A; Takeuchi M; Matsue K
    Jpn J Clin Oncol; 2019 Feb; 49(2):195-198. PubMed ID: 30608548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis.
    Bryce AH; Ketterling RP; Gertz MA; Lacy M; Knudson RA; Zeldenrust S; Kumar S; Hayman S; Buadi F; Kyle RA; Greipp PR; Lust JA; Russell S; Rajkumar SV; Fonseca R; Dispenzieri A
    Haematologica; 2009 Mar; 94(3):380-6. PubMed ID: 19211640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen.
    Dumas B; Yameen H; Sarosiek S; Sloan JM; Sanchorawala V
    Amyloid; 2020 Dec; 27(4):244-249. PubMed ID: 32551974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous light chain amyloidosis with multiple myeloma: A concise review.
    Andrei M; Wang JC
    Hematol Oncol Stem Cell Ther; 2019 Jun; 12(2):71-81. PubMed ID: 30261180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AL amyloidosis: The effect of fluorescent in situ hybridization abnormalities on organ involvement and survival.
    Ozga M; Zhao Q; Benson D; Elder P; Williams N; Bumma N; Rosko A; Chaudhry M; Khan A; Devarakonda S; Kahwash R; Vallakati A; Campbell C; Parikh SV; Almaani S; Prosek J; Bittengle J; Pfund K; LoRusso S; Freimer M; Redder E; Efebera Y; Sharma N
    Cancer Med; 2021 Feb; 10(3):965-973. PubMed ID: 33347707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of oral examination in newly diagnosed multiple myeloma patients: A safe and simple way to detect light chain amyloidosis.
    Leiba M; Jarjoura S; Abboud W; Nagler A; Yahalom R; Duek A; Yarom N
    Oral Dis; 2018 Oct; 24(7):1343-1348. PubMed ID: 29791070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of Plasmin-α2-plasmin Inhibitor Complex Predicts the Diagnosis of Systemic AL Amyloidosis in Patients with Monoclonal Protein.
    Ishiguro K; Hayashi T; Yokoyama Y; Aoki Y; Onodera K; Ikeda H; Ishida T; Nakase H
    Intern Med; 2018 Mar; 57(6):783-788. PubMed ID: 29021469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosis.
    Dinner S; Witteles W; Witteles R; Lam A; Arai S; Lafayette R; George TI; Schrier SL; Liedtke M
    Br J Haematol; 2013 May; 161(3):367-72. PubMed ID: 23432783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Venetoclax monotherapy induced rapid and sustained response in a frail patient with refractory AL amyloidosis: Less is more?
    Yip PL; Lau JSM; Lam CP
    Int J Hematol; 2020 Aug; 112(2):234-237. PubMed ID: 32207051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?
    Leiba M; Duek A; Amariglio N; Avigdor A; Benyamini N; Hardan I; Zilbershats I; Ganzel C; Shevetz O; Novikov I; Cohen Y; Ishoev G; Rozic G; Nagler A; Trakhtenbrot L
    Genes Chromosomes Cancer; 2016 Sep; 55(9):710-8. PubMed ID: 27152944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant.
    Chang H; Sloan S; Li D; Zhuang L; Yi QL; Chen CI; Reece D; Chun K; Keith Stewart A
    Br J Haematol; 2004 Apr; 125(1):64-8. PubMed ID: 15015970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Transformation' from amyloid light chain amyloidosis to symptomatic multiple myeloma.
    Rutten KHG; Raymakers RAP; Minnema MC
    Neth J Med; 2018 Jul; 76(5):249-250. PubMed ID: 30019681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translocation t(11;14) is associated with adverse outcome in patients with newly diagnosed AL amyloidosis when treated with bortezomib-based regimens.
    Bochtler T; Hegenbart U; Kunz C; Granzow M; Benner A; Seckinger A; Kimmich C; Goldschmidt H; Ho AD; Hose D; Jauch A; Schönland SO
    J Clin Oncol; 2015 Apr; 33(12):1371-8. PubMed ID: 25779559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14).
    Bochtler T; Hegenbart U; Heiss C; Benner A; Moos M; Seckinger A; Pschowski-Zuck S; Kirn D; Neben K; Bartram CR; Ho AD; Goldschmidt H; Hose D; Jauch A; Schonland SO
    Blood; 2011 Apr; 117(14):3809-15. PubMed ID: 21310923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of venetoclax-based therapy in patients with t(11;14) light chain amyloidosis after failure of daratumumab-based therapy.
    Dima D; Hughes M; Orland M; Ullah F; Goel U; Anwer F; Raza S; Mazzoni S; Bhutani D; Williams L; Lentzsch S; Samaras C; Valent J; Chakraborty R; Khouri J
    Amyloid; 2024 Sep; 31(3):195-201. PubMed ID: 38956891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Myeloma Light Chain Amyloidosis Presenting as Hepatic Failure.
    Elgouhari H; Ahmed K; Niazi M; Huntington MK
    S D Med; 2018 Mar; 71(3):112-115. PubMed ID: 29991097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple myeloma associated with amyloidosis and t(1;20)(q21;q11) translocation.
    Otokida K; Yoshida H; Mizunuma Y; Yamada M; Hiramori K
    Tohoku J Exp Med; 1990 Dec; 162(4):363-5. PubMed ID: 2102567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma.
    He H; Lu J; Qiang W; Liu J; Liang A; Du J
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myeloma.
    Bochtler T; Merz M; Hielscher T; Granzow M; Hoffmann K; Krämer A; Raab MS; Hillengass J; Seckinger A; Kimmich C; Dittrich T; Müller-Tidow C; Hose D; Goldschmidt H; Hegenbart U; Jauch A; Schönland SO
    Blood Adv; 2018 Oct; 2(20):2607-2618. PubMed ID: 30327369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of IGLV2-14 light chain sequences of patients with AL amyloidosis or multiple myeloma.
    Berghaus N; Schreiner S; Poos AM; Raab MS; Goldschmidt H; Mai EK; Salwender HJ; Bernhard H; Thurner L; Müller-Tidow C; Weinhold N; Hegenbart U; Schönland SO; Huhn S
    FEBS J; 2023 Sep; 290(17):4256-4267. PubMed ID: 37097223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.